{
    "2019-04-04": [
        [
            {
                "time": "",
                "original_text": "利润暴增难阻股价跳水 智飞生物重磅疫苗面临停产",
                "features": {
                    "keywords": [
                        "利润暴增",
                        "股价跳水",
                        "智飞生物",
                        "重磅疫苗",
                        "停产"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【智飞生物】年报点评：重磅品种高增长可持续，三联苗暂停影响有限",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "重磅品种",
                        "高增长",
                        "三联苗",
                        "暂停"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "宫颈癌疫苗大卖 智飞生物去年盈利翻倍",
                "features": {
                    "keywords": [
                        "宫颈癌疫苗",
                        "智飞生物",
                        "盈利翻倍"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物“业绩飘红”背后：独家重磅疫苗面临停产 去年批签发量达到643万支",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩飘红",
                        "独家重磅疫苗",
                        "停产",
                        "批签发量"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)一季度净利润预增85%-105%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "一季度",
                        "净利润",
                        "预增",
                        "85%-105%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2019年首季净利同比将翻倍 HPV疫苗两年半基础采购额超180亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2019年",
                        "首季",
                        "净利",
                        "HPV疫苗",
                        "采购额"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2018年净利增逾两倍 研发投入同比大增81.55%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2018年",
                        "净利",
                        "研发投入",
                        "大增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2018年实现净利润14.51亿元 同比增长235.75% 拟10派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2018年",
                        "净利润",
                        "同比增长",
                        "拟10派5元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物一季度业绩预增85%至105%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "一季度",
                        "业绩",
                        "预增",
                        "85%-105%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：AC-Hib三联苗和HPV疫苗驱动业绩高速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "AC-Hib三联苗",
                        "HPV疫苗",
                        "业绩",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "聚焦生物医药领域 六只个股腾飞在即掘良机",
                "features": {
                    "keywords": [
                        "生物医药",
                        "个股",
                        "腾飞",
                        "良机"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：2019年第一季度业绩报告预告",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2019年",
                        "第一季度",
                        "业绩报告",
                        "预告"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物:多品种驱动 高速增长持续",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "多品种",
                        "驱动",
                        "高速增长",
                        "持续"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}